Anti-Mullerian hormone test. Ovarian dysfunction
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1- Women of reproductive age (18-39) 2- Women with primary infertility 3- Women with decreased ovarian reserve test 4- Women without a history of chronic medical disease (diabetes, blood pressure, heart disease, kidney disease, etc.) 5- Women with unexplained infertility
Exclusion criteria
Exclusion criteria: 1- Unwillingness to participate in the study 2- Patients with diabetes 3- Non-smoking 4- No chemotherapy or radiotherapy 5- No neurological or psychiatric diseases 6- No autoimmune diseases7- Abnormal BMI
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anti-Mullerian hormone. Timepoint: Anti-Mullerian Hormone Measurement Before Taking Medication. Method of measurement: Determining and comparing AMH hormone levels in women with primary infertility before and after intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparing AMH hormone levels in women with primary infertility before and after intervention based on age groups. Timepoint: 2- Determining and comparing AMH hormone levels in women with primary infertility before and after intervention based on age groups. Method of measurement: The anti-Mullerian hormone test is used to measure the relevant outcome. The test results are compared before and after the intervention. | — |
Countries
Iran (Islamic Republic of)
Contacts
Yasouj University of Medical Sciences